Spontaneous tumor lysis syndrome in adrenal adenocarcinoma: a case report and review of the literature.
Adrenal adenocarcinoma
Solid tumor
Spontaneous tumor lysis syndrome
Journal
Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382
Informations de publication
Date de publication:
10 Feb 2022
10 Feb 2022
Historique:
received:
20
01
2021
accepted:
06
01
2022
entrez:
10
2
2022
pubmed:
11
2
2022
medline:
12
2
2022
Statut:
epublish
Résumé
Tumor lysis syndrome is an oncologic emergency that classically occurs following cancer therapy, although spontaneous tumor lysis syndrome can also occur in malignancies, albeit rarely. Spontaneous tumor lysis syndrome has previously been reported in some hematologic malignancies, but it rarely happens in solid tumors and seems to be associated with a higher mortality rate. This is the first case of adrenal adenocarcinoma that developed spontaneous tumor lysis syndrome. We present a rare case of spontaneous tumor lysis syndrome occurring in a patient previously diagnosed with adrenal adenocarcinoma. The patient was a 64-year-old Persian man with abdominal pain, hypersomnia, and fatigue who was previously diagnosed with right adrenocortical carcinoma and had undergone right adrenalectomy with regional lymph nodes resection 5 months previously. On physical examination, the patient had abdominal distension and mild tenderness at the right upper quadrant. Pitting edema was detected bilaterally in the lower extremities. Initial imaging revealed multiple and large lesions suggestive of liver metastases. The laboratory data showed hyperkalemia, hyperuricemia, hyperphosphatemia, and elevated serum creatinine level indicative of spontaneous tumor lysis syndrome in the patient. Despite immediate and intensive care with antibiotics, hydration, treatment with a hypouricemic agent, and renal replacement therapy, the patient ultimately died from multiorgan failure. Tumor lysis syndrome in solid tumors has high mortality. Patients susceptible to spontaneous tumor lysis syndrome must receive aggressive treatment immediately, which is crucial for preventing morbidity and mortality. Spontaneous tumor lysis syndrome may be underdiagnosed, and a high degree of clinical suspicion is needed to make the diagnosis and proceed with required interventions. Therefore, clinicians should be aware of this rare phenomenon.
Sections du résumé
BACKGROUND
BACKGROUND
Tumor lysis syndrome is an oncologic emergency that classically occurs following cancer therapy, although spontaneous tumor lysis syndrome can also occur in malignancies, albeit rarely. Spontaneous tumor lysis syndrome has previously been reported in some hematologic malignancies, but it rarely happens in solid tumors and seems to be associated with a higher mortality rate. This is the first case of adrenal adenocarcinoma that developed spontaneous tumor lysis syndrome.
CASE PRESENTATION
METHODS
We present a rare case of spontaneous tumor lysis syndrome occurring in a patient previously diagnosed with adrenal adenocarcinoma. The patient was a 64-year-old Persian man with abdominal pain, hypersomnia, and fatigue who was previously diagnosed with right adrenocortical carcinoma and had undergone right adrenalectomy with regional lymph nodes resection 5 months previously. On physical examination, the patient had abdominal distension and mild tenderness at the right upper quadrant. Pitting edema was detected bilaterally in the lower extremities. Initial imaging revealed multiple and large lesions suggestive of liver metastases. The laboratory data showed hyperkalemia, hyperuricemia, hyperphosphatemia, and elevated serum creatinine level indicative of spontaneous tumor lysis syndrome in the patient. Despite immediate and intensive care with antibiotics, hydration, treatment with a hypouricemic agent, and renal replacement therapy, the patient ultimately died from multiorgan failure.
CONCLUSIONS
CONCLUSIONS
Tumor lysis syndrome in solid tumors has high mortality. Patients susceptible to spontaneous tumor lysis syndrome must receive aggressive treatment immediately, which is crucial for preventing morbidity and mortality. Spontaneous tumor lysis syndrome may be underdiagnosed, and a high degree of clinical suspicion is needed to make the diagnosis and proceed with required interventions. Therefore, clinicians should be aware of this rare phenomenon.
Identifiants
pubmed: 35139902
doi: 10.1186/s13256-022-03263-4
pii: 10.1186/s13256-022-03263-4
pmc: PMC8830132
doi:
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
52Informations de copyright
© 2022. The Author(s).
Références
Rare Tumors. 2014 Jun 13;6(2):5389
pubmed: 25002953
Clin Oncol (R Coll Radiol). 2006 Dec;18(10):773-80
pubmed: 17168213
Clinics (Sao Paulo). 2009 May;64(5):479-81
pubmed: 19488615
Br J Haematol. 2015 Jun;169(5):661-71
pubmed: 25876990
J Community Hosp Intern Med Perspect. 2020 Jun 14;10(3):269-272
pubmed: 32850076
Br J Haematol. 2004 Oct;127(1):3-11
pubmed: 15384972
N Engl J Med. 2011 May 12;364(19):1844-54
pubmed: 21561350
Clin Case Rep. 2017 Nov 13;5(12):2121-2126
pubmed: 29225869
Turk J Emerg Med. 2020 Jul 18;20(3):142-145
pubmed: 32832733
Haematologica. 2008 Jan;93(1):9-13
pubmed: 18166779